Xingfang Guo

1.0k total citations · 1 hit paper
14 papers, 815 citations indexed

About

Xingfang Guo is a scholar working on Neurology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Xingfang Guo has authored 14 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Epidemiology. Recurrent topics in Xingfang Guo's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Nerve injury and regeneration (2 papers) and Photoreceptor and optogenetics research (1 paper). Xingfang Guo is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Nerve injury and regeneration (2 papers) and Photoreceptor and optogenetics research (1 paper). Xingfang Guo collaborates with scholars based in China, United States and Australia. Xingfang Guo's co-authors include Nian Xiong, Kai Ma, Jinsha Huang, Yun Xia, Guoxin Zhang, Fang Wan, Chao Han, Zhicheng Lin, Tao Wang and Luxi Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Cellular and Molecular Life Sciences and Cell Death and Disease.

In The Last Decade

Xingfang Guo

14 papers receiving 810 citations

Hit Papers

Weight Loss and Malnutrition in Patients with Parkinson's... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingfang Guo China 11 327 258 200 180 119 14 815
Ruiming Zhu China 19 198 0.6× 377 1.5× 137 0.7× 156 0.9× 178 1.5× 33 866
Burak Yuluğ Türkiye 21 269 0.8× 314 1.2× 378 1.9× 217 1.2× 223 1.9× 86 1.3k
Magdalena Cieślik Poland 18 119 0.4× 259 1.0× 118 0.6× 190 1.1× 98 0.8× 33 749
Eve M. Simcox United Kingdom 5 475 1.5× 321 1.2× 125 0.6× 195 1.1× 250 2.1× 5 913
Dirk Luchtman Canada 15 171 0.5× 206 0.8× 263 1.3× 186 1.0× 188 1.6× 19 1.0k
Haifeng Shu China 18 182 0.6× 358 1.4× 165 0.8× 165 0.9× 327 2.7× 57 1.3k
Jingde Dong China 17 149 0.5× 227 0.9× 112 0.6× 122 0.7× 310 2.6× 37 856
Tenghong Lian China 14 385 1.2× 119 0.5× 149 0.7× 136 0.8× 92 0.8× 36 740
Emiliano Fernández‐Villalba Spain 20 505 1.5× 320 1.2× 470 2.4× 208 1.2× 429 3.6× 48 1.3k

Countries citing papers authored by Xingfang Guo

Since Specialization
Citations

This map shows the geographic impact of Xingfang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingfang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingfang Guo more than expected).

Fields of papers citing papers by Xingfang Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingfang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingfang Guo. The network helps show where Xingfang Guo may publish in the future.

Co-authorship network of co-authors of Xingfang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xingfang Guo. A scholar is included among the top collaborators of Xingfang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingfang Guo. Xingfang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Luo, Yuqi, Xingfang Guo, Wanlin Yang, et al.. (2023). Healthy Human Fecal Microbiota Transplantation into Mice Attenuates MPTP-Induced Neurotoxicity via AMPK/SOD2 Pathway. Aging and Disease. 14(6). 2193–2193. 42 indexed citations
2.
Liu, Hailing, Zifeng Huang, Bin Deng, et al.. (2022). QEEG Signatures are Associated with Nonmotor Dysfunctions in Parkinson's Disease and Atypical Parkinsonism: An Integrative Analysis. Aging and Disease. 14(1). 204–204. 12 indexed citations
3.
Zhu, Shuzhen, Xiaoyan Xu, Yuqi Luo, et al.. (2021). The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson’s Disease: What We Know and Where to Go. Aging and Disease. 12(7). 1675–1675. 22 indexed citations
4.
Guo, Xingfang, Bin Deng, Fen Xie, et al.. (2021). Fibrinogen is an Independent Risk Factor for White Matter Hyperintensities in CADASIL but not in Sporadic Cerebral Small Vessel Disease Patients. Aging and Disease. 12(3). 801–801. 10 indexed citations
5.
Li, Jingwen, Xi Long, Ting Zhou, et al.. (2019). Multiple pathways for natural product treatment of Parkinson's disease: A mini review. Phytomedicine. 60. 152954–152954. 30 indexed citations
6.
Han, Chao, Nian Xiong, Xingfang Guo, et al.. (2019). Exosomes from patients with Parkinson’s disease are pathological in mice. Journal of Molecular Medicine. 97(9). 1329–1344. 76 indexed citations
7.
Kou, Liang, Jinsha Huang, Chao Han, et al.. (2019). Cluster-Like Headache Secondary to Anamnesis of Sphenoid Ridge Meningioma: A Case Report and Literature Review. Frontiers in Neurology. 10. 23–23. 2 indexed citations
8.
Guo, Xingfang, Chao Han, Kai Ma, et al.. (2019). Hydralazine Protects Nigrostriatal Dopaminergic Neurons From MPP+ and MPTP Induced Neurotoxicity: Roles of Nrf2-ARE Signaling Pathway. Frontiers in Neurology. 10. 271–271. 29 indexed citations
9.
Xia, Yun, Guoxin Zhang, Chao Han, et al.. (2019). Microglia as modulators of exosomal alpha-synuclein transmission. Cell Death and Disease. 10(3). 174–174. 176 indexed citations
10.
Ma, Kai, Chao Han, Guoxin Zhang, et al.. (2019). Reduced VMAT2 expression exacerbates the hyposmia in the MPTP model of Parkinson's disease. Biochemical and Biophysical Research Communications. 513(2). 306–312. 10 indexed citations
11.
Zhang, Guoxin, Yun Xia, Fang Wan, et al.. (2018). New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease. Frontiers in Aging Neuroscience. 10. 370–370. 82 indexed citations
12.
Ma, Kai, Nian Xiong, Yan Shen, et al.. (2018). Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects. Frontiers in Aging Neuroscience. 10. 1–1. 307 indexed citations breakdown →
13.
Shen, Yan, Xiaoming Liu, Xi Long, et al.. (2017). Novel VPS13A Gene Mutations Identified in Patients Diagnosed with Chorea-acanthocytosis (ChAc): Case Presentation and Literature Review. Frontiers in Aging Neuroscience. 9. 95–95. 7 indexed citations
14.
Shen, Yan, Xingfang Guo, Chao Han, et al.. (2017). The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson’s disease. Cellular and Molecular Life Sciences. 74(20). 3741–3768. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026